Axonics (NASDAQ:AXNX) said it acquired a lead placement solution from Radian which complements the company's existing sacral neuromodulation (SNM) offering. The company acquired the assets of Radian ...
Neuspera® Medical, Inc., the leading developer of integrated technologies powering the future of neuromodulation, today announced a milestone patient revision from a traditional sacral neuromodulation ...
Medtech analysts at Needham & Co. surveyed 25 urologists that reported doing a median of 30 sacral neuromodulation procedures a year. While the survey implications weren't necessarily bad for Axonics, ...
PARK CITY, Utah, Nov. 6, 2023 /PRNewswire/ -- BlueWind Medical, Ltd., a pioneer in the development and commercialization of a patient centric implantable Tibial NeuroModulation (iTNM) solution for ...
NASHVILLE, Tenn.--(BUSINESS WIRE)--Turing Medical, the leader in precision targeting for neuromodulation therapies, today announced the launch of Bullsai, its new brain mapping and targeting solution, ...
Gastroesophageal reflux disease (GERD) is a prevalent chronic condition characterized by recurrent reflux of stomach contents into the esophagus, leading to troublesome symptoms such as heartburn, ...
LivaNova PLC (NASDAQ:LIVN) has moved into sharper market focus as trading flows reflect heightened positioning adjustments ...
Neuromodulation has been a fast-growing area of medicine for at least a decade. Despite becoming an increasingly common way to treat chronic pain, neurological disorders, and even psychiatric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results